ADVERTISEMENT

Comments?
Help us improve Portfolio Grader.


Comments?
Help us improve Portfolio Grader.


Blue Chip Growth

Stock Report: "HeartWare International, Inc." (HTWR) Report Updated: Jul 25, 2016 | Print This Page

Get more stock ratings by Louis Navellier

"HeartWare International, Inc." (HTWR)

Rating: Hold Volatility: Aggressive
Total Grade: C Industry: Health Care Equipment & Supplies
Competitors: ISRG,FONR,ELMD,CEMI

Stock Analysis

Rating: Monthly View

A
B
C
D
F
July August September October November December January February March April May June

Rating: Weekly View

This Week: C down no change
Last Week: C same no change
Two Weeks Ago: C up no change
service keys

"HeartWare International, Inc."© quotemedia

Company Profile

HeartWare International, Inc., a medical device company, designs, develops, manufactures, and markets miniaturized implantable heart pumps or ventricular assist devices (VAD) for the treatment of advanced heart failure in the United States, Germany, and internationally. It offers HeartWare Ventricular Assist System, which comprises a VAD or blood pump, patient accessories, and surgical tools designed to provide circulatory support for patients in the advanced stage of heart failure. The company is also developing the MVAD, a miniaturized blood pump intended for chronic heart failure patients; and SYNERGY Circulatory Support System, a partial support system designed to treat less sick, ambulatory, chronic heart failure patients who are not yet inotrope-dependent. The company markets its products directly to clinicians and medical facilities, as well as through medical device distributors. HeartWare International, Inc. is headquartered in Framingham, Massachusetts.